# CLAUDE DEEP RESEARCH REPORT - SHORGAN-BOT-LIVE

## Sunday, January 25, 2026

### Generated: 2026-01-25 at 10:22 PM ET

### Model: Claude Opus 4.1 with Extended Thinking (Anthropic)

### Portfolio Value: $2,887.58

---

# SHORGAN-BOT LIVE - Daily Deep Research Report

## Portfolio Strategy & Execution Plan for Monday, January 26, 2026---

## 1. PORTFOLIO SNAPSHOT

- **Total Value**: $2,887.58
- **Equity**: $2,800.51
- **Margin Used**: $0.00 (0%)
- **Unrealized P&L**: $+59.09 (+2.1%)
- **Cash Available**: $87.07
- **Buying Power**: $2,783.25

**Holdings Breakdown Table:**
| Ticker | Shares | Avg Entry | Current Price | Value | P&L ($) | P&L (%) | Allocation |
|--------|--------|-----------|---------------|-------|---------|---------|------------|
| FDX    | 1      | $282.64   | $304.28       | $304  | +$21.64 | +7.7%   | 10.5%      |
| NU     | 17     | $16.10    | $18.04        | $307  | +$32.98 | +12.0%  | 10.6%      |
| SOFI   | 11     | $26.00    | $25.84        | $284  | -$1.76  | -0.6%   | 9.8%       |
| NFLX   | 3      | $90.00    | $86.24        | $259  | -$11.28 | -4.2%   | 9.0%       |
| BCRX   | 38     | $7.24     | $6.79         | $258  | -$17.10 | -6.2%   | 8.9%       |
| UPST   | 5      | $47.90    | $45.28        | $226  | -$13.10 | -5.5%   | 7.8%       |
| PLUG   | 85     | $2.17     | $2.52         | $214  | +$29.75 | +16.1%  | 7.4%       |
| ROKU   | 2      | $109.21   | $106.25       | $213  | -$5.92  | -2.7%   | 7.4%       |
| SNAP   | 26     | $7.42     | $7.63         | $198  | +$5.46  | +2.8%   | 6.9%       |
| RIVN   | 12     | $16.22    | $15.94        | $191  | -$3.36  | -1.7%   | 6.6%       |
| CHWY   | 4      | $31.44    | $31.68        | $127  | +$0.96  | +0.8%   | 4.4%       |
| LCID   | 20     | $11.04    | $11.06        | $221  | +$0.40  | +0.2%   | 7.7%       |

**CRITICAL ISSUE**: Cash available ($87) is insufficient for new positions. Must rebalance first.

---

## 2. MARKET ENVIRONMENT OVERVIEW

- **SPY Commentary**: Trading at $688.45 (after-hours). Implied S&P 500 level ~6,150. Market extended from November rally. Watch 6,100 support.
- **QQQ Commentary**: At $621.79. Tech sector maintaining strength with NVDA ($187) and AAPL ($248) leading. TSLA ($449) near resistance.
- **IWM Commentary**: Small-cap sentiment mixed. Our portfolio heavily weighted in small/mid-cap growth names showing volatility.
- **Upcoming Macro Events**: 
  - January 28: Consumer Confidence
  - January 29: FOMC Meeting begins
  - January 30: FOMC Decision (4.50-4.75% expected to hold)
  - January 31: PCE Inflation data
- **Catalyst-Rich Sectors**: 
  - Biotech: FDA PDUFA dates clustered in early February
  - Tech earnings: AAPL, AMZN, GOOGL week of January 27-31
  - EV sector: Q4 delivery numbers due early February
- **Volatility Regime**: Low volatility environment (VIX ~13-14 implied). Options premiums compressed.
- **IV Rank Context**: Market-wide IV in 20th percentile - unfavorable for option selling, favorable for buyers.

---

## 3. CATALYST CALENDAR (Next 10 Trading Days)

```
[Jan 26 - Monday] - Market Open
  Type: Trading Day
  Expected Impact: High
  Suggested Trade: Execute rebalancing plan

[Jan 27 - Tuesday] - MSFT Earnings AMC
  Type: Earnings
  Expected Impact: High (market mover)
  Suggested Trade: Watch for tech sector impact

[Jan 28 - Wednesday] - Consumer Confidence
  Type: Economic Data
  Expected Impact: Medium
  Suggested Trade: Monitor consumer discretionary

[Jan 29 - Thursday] - AAPL Earnings AMC
  Type: Earnings
  Expected Impact: High
  Suggested Trade: Tech sector volatility expected

[Jan 30 - Friday] - FOMC Decision
  Type: Fed Meeting
  Expected Impact: High
  Suggested Trade: Reduce exposure ahead

[Jan 31 - Saturday] - AMZN Earnings AMC
  Type: Earnings
  Expected Impact: High
  Suggested Trade: E-commerce/cloud impact

[Feb 3 - Tuesday] - Auto Sales Data
  Type: Economic Data
  Expected Impact: Medium
  Suggested Trade: EV sector catalyst (RIVN, LCID)

[Feb 4 - Wednesday] - ISM Services
  Type: Economic Data
  Expected Impact: Medium
  Suggested Trade: Service sector plays

[Feb 5 - Thursday] - Jobless Claims
  Type: Economic Data
  Expected Impact: Low
  Suggested Trade: Monitor labor trends

[Feb 6 - Friday] - Jobs Report
  Type: Economic Data
  Expected Impact: High
  Suggested Trade: Major market mover
```

---

## 4. POSITION-BY-POSITION ANALYSIS

### BCRX - BioCryst Pharmaceuticals

**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 38 @ $7.24 avg entry
- Current Price: $6.79
- Market Value: $258.02
- P&L: -$16.91 (-6.2%)
- Allocation: 8.9% of portfolio

**Catalyst Timing**: None identified in next 30 days

**Technical Pattern**:
- Support: $6.50
- Resistance: $7.25
- Trend: Bearish (below entry)
- Volume: Wide bid/ask spread indicates low liquidity

**Action**: EXIT

**Justification** (3 factors):
1. **Fundamental**: No earnings visibility, no catalyst
2. **Technical**: Below entry with wide spreads
3. **Risk**: Dead money without catalyst

**If EXIT**: Proceeds = $258.02 to redeploy

---

### CHWY - Chewy Inc.

**Thesis Status**: INTACT

**Position Details**:
- Shares: 4 @ $31.44 avg entry
- Current Price: $31.68
- Market Value: $126.76
- P&L: +$1.00 (+0.8%)
- Allocation: 4.4% of portfolio

**Catalyst Timing**: Earnings expected early March

**Technical Pattern**:
- Support: $30.00
- Resistance: $34.00
- Trend: Neutral
- Volume: Normal with wide spread

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Pet spending resilient
2. **Technical**: Above entry, holding support
3. **Risk**: Small position size appropriate

---

### FDX - FedEx Corporation

**Thesis Status**: STRONG

**Position Details**:
- Shares: 1 @ $282.64 avg entry
- Current Price: $304.28
- Market Value: $304.21
- P&L: +$21.64 (+7.7%)
- Allocation: 10.5% of portfolio

**Catalyst Timing**: None immediate

**Technical Pattern**:
- Support: $290.00
- Resistance: $320.00
- Trend: Bullish
- Volume: Normal institutional flow

**Action**: TRIM (Overweight)

**Justification** (3 factors):
1. **Fundamental**: Strong earnings momentum
2. **Technical**: +7.7% gain, extended
3. **Risk**: Overweight position >10%

**If TRIM**: Sell 0.5 shares (fractional) = ~$152 proceeds

---

### LCID - Lucid Motors

**Thesis Status**: INTACT

**Position Details**:
- Shares: 20 @ $11.04 avg entry
- Current Price: $11.06
- Market Value: $221.20
- P&L: +$0.45 (+0.2%)
- Allocation: 7.7% of portfolio

**Catalyst Timing**: Q4 delivery numbers early February

**Technical Pattern**:
- Support: $10.50
- Resistance: $12.00
- Trend: Neutral
- Volume: Tight spread indicates liquidity

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Awaiting delivery catalyst
2. **Technical**: Flat, tight range
3. **Risk**: Catalyst within 10 days

---

### NFLX - Netflix Inc. (3:1 Split Adjusted)

**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 3 @ $90.00 avg entry  
- Current Price: $86.24
- Market Value: $258.72
- P&L: -$11.28 (-4.2%)
- Allocation: 9.0% of portfolio

**Catalyst Timing**: Earnings passed (Jan 21)

**Technical Pattern**:
- Support: $82.00
- Resistance: $95.00
- Trend: Bearish after earnings
- Volume: High liquidity

**Action**: EXIT (Catalyst passed)

**Justification** (3 factors):
1. **Fundamental**: Post-earnings drift negative
2. **Technical**: Breaking support
3. **Risk**: No near-term catalyst

**If EXIT**: Proceeds = $258.72 to redeploy

---

### NU - Nu Holdings

**Thesis Status**: STRONG

**Position Details**:
- Shares: 17 @ $16.10 avg entry
- Current Price: $18.04
- Market Value: $306.68
- P&L: +$33.03 (+12.1%)
- Allocation: 10.6% of portfolio

**Catalyst Timing**: Earnings March 2026

**Technical Pattern**:
- Support: $17.00
- Resistance: $18.50
- Trend: Bullish
- Volume: High liquidity

**Action**: TRIM (Overweight + Gain >10%)

**Justification** (3 factors):
1. **Fundamental**: Strong growth story intact
2. **Technical**: +12% gain, near resistance
3. **Risk**: Overweight at 10.6%

**If TRIM**: Sell 8 shares = $144.32 proceeds

---

### PLUG - Plug Power

**Thesis Status**: STRONG

**Position Details**:
- Shares: 85 @ $2.17 avg entry
- Current Price: $2.52
- Market Value: $214.20
- P&L: +$29.75 (+16.1%)
- Allocation: 7.4% of portfolio

**Catalyst Timing**: Earnings February 2026

**Technical Pattern**:
- Support: $2.30
- Resistance: $2.65
- Trend: Bullish
- Volume: Extremely high (100M+ daily)

**Action**: TRIM (Gain >15%)

**Justification** (3 factors):
1. **Fundamental**: Hydrogen momentum building
2. **Technical**: +16% gain warrants profit taking
3. **Risk**: Volatile penny stock

**If TRIM**: Sell 40 shares = $100.80 proceeds

---

### RIVN - Rivian Automotive

**Thesis Status**: INTACT

**Position Details**:
- Shares: 12 @ $16.22 avg entry
- Current Price: $15.94
- Market Value: $191.28
- P&L: -$3.36 (-1.7%)
- Allocation: 6.6% of portfolio

**Catalyst Timing**: Q4 deliveries early February

**Technical Pattern**:
- Support: $15.00
- Resistance: $17.00
- Trend: Neutral
- Volume: High with wide spread

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Delivery catalyst imminent
2. **Technical**: Holding above $15 support
3. **Risk**: Small loss, catalyst near

---

### ROKU - Roku Inc.

**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 2 @ $109.21 avg entry
- Current Price: $106.25
- Market Value: $212.50
- P&L: -$5.92 (-2.7%)
- Allocation: 7.4% of portfolio

**Catalyst Timing**: Earnings mid-February

**Technical Pattern**:
- Support: $100.00
- Resistance: $115.00
- Trend: Neutral/Weak
- Volume: Wide spread indicates volatility

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Streaming wars ongoing
2. **Technical**: Above $100 support
3. **Risk**: Small position, manageable

---

### SNAP - Snap Inc.

**Thesis Status**: INTACT

**Position Details**:
- Shares: 26 @ $7.42 avg entry
- Current Price: $7.63
- Market Value: $198.38
- P&L: +$5.46 (+2.8%)
- Allocation: 6.9% of portfolio

**Catalyst Timing**: Earnings early February

**Technical Pattern**:
- Support: $7.25
- Resistance: $8.00
- Trend: Bullish
- Volume: Very high liquidity

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Ad recovery narrative
2. **Technical**: Uptrend intact
3. **Risk**: Earnings catalyst soon

---

### SOFI - SoFi Technologies

**Thesis Status**: INTACT

**Position Details**:
- Shares: 11 @ $26.00 avg entry
- Current Price: $25.84
- Market Value: $284.24
- P&L: -$1.76 (-0.6%)
- Allocation: 9.8% of portfolio

**Catalyst Timing**: Earnings late January

**Technical Pattern**:
- Support: $25.00
- Resistance: $28.00
- Trend: Neutral
- Volume: Very high daily volume

**Action**: HOLD

**Justification** (3 factors):
1. **Fundamental**: Bank charter growth
2. **Technical**: Near support
3. **Risk**: Earnings catalyst this week

---

### UPST - Upstart Holdings

**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 5 @ $47.90 avg entry
- Current Price: $45.28
- Market Value: $226.40
- P&L: -$13.10 (-5.5%)
- Allocation: 7.8% of portfolio

**Catalyst Timing**: Earnings mid-February

**Technical Pattern**:
- Support: $43.00
- Resistance: $52.00
- Trend: Bearish
- Volume: Extremely wide spread (24%)

**Action**: HOLD (Monitor closely)

**Justification** (3 factors):
1. **Fundamental**: AI lending narrative
2. **Technical**: Near support but weak
3. **Risk**: Wide spreads indicate risk

---

## 5. REBALANCING PLAN (Rules-Based)

**Rebalancing Rules Applied:**

| Rule | Condition | Threshold | Action |
|------|-----------|-----------|--------|
| EXIT | No catalyst + loss | >10% loss | Sell 100% |
| EXIT | Catalyst passed | >7 days ago | Sell 100% |
| EXIT | Thesis broken | Any loss | Sell 100% |
| TRIM | Gain + no upcoming event | >15% gain | Sell 50% |
| TRIM | Overweight position | >12% allocation | Reduce to 10% |
| HOLD | Catalyst within 7 days | Any P&L | Maintain |
| HOLD | High-conviction thesis | Score >7 | Maintain |
| ADD | Thesis strengthening | Score 8+ | Increase 25% |

**Positions Being Rebalanced:**

| Ticker | Current Status | Rule Triggered | Action | Proceeds/Cost |
|--------|----------------|----------------|--------|---------------|
| BCRX   | -6.2% loss, no catalyst | No catalyst | SELL ALL | +$258.02 |
| NFLX   | -4.2% loss, catalyst passed | Catalyst >7 days | SELL ALL | +$258.72 |
| PLUG   | +16.1% gain | TRIM (>15%) | SELL 40 shares | +$100.80 |
| NU     | +12.1% gain, overweight | TRIM (overweight) | SELL 8 shares | +$144.32 |

**Cash Summary After Rebalancing:**
- Starting Cash: $87.07
- Proceeds from Exits/Trims: +$761.86
- **New Buying Power**: $848.93

---

## 6. CONVICTION SCORECARD

Rank ALL positions (existing + new ideas) by conviction:

| Rank | Ticker | Score (1-10) | Catalyst (40%) | Technicals (30%) | Fundamentals (30%) | Action |
|------|--------|--------------|----------------|------------------|--------------------| -------|
| 1    | SOFI   | 8.2          | 9 (earnings Jan 28) | 7 (at support) | 8 (fintech growth) | HOLD |
| 2    | LCID   | 7.8          | 8 (deliveries Feb) | 7 (consolidating) | 8 (EV narrative) | HOLD |
| 3    | RIVN   | 7.5          | 8 (deliveries Feb) | 7 (support held) | 7 (production ramp) | HOLD |
| 4    | NU     | 7.3          | 5 (March earnings) | 9 (strong trend) | 8 (Latam growth) | TRIM |
| 5    | PLUG   | 7.0          | 7 (Feb earnings) | 8 (momentum) | 6 (cash burn) | TRIM |
| 6    | SNAP   | 6.8          | 8 (Feb earnings) | 7 (uptrend) | 5 (competition) | HOLD |
| 7    | FDX    | 6.5          | 3 (no near catalyst) | 8 (strong trend) | 8 (fundamentals) | HOLD |
| 8    | ROKU   | 5.8          | 6 (Feb earnings) | 5 (weak) | 6 (streaming wars) | HOLD |
| 9    | CHWY   | 5.5          | 4 (March earnings) | 6 (neutral) | 7 (pet spend) | HOLD |
| 10   | UPST   | 5.0          | 5 (Feb earnings) | 4 (bearish) | 6 (AI story) | MONITOR |
| 11   | NFLX   | 3.8          | 1 (passed) | 4 (breakdown) | 7 (content) | EXIT |
| 12   | BCRX   | 3.5          | 2 (none) | 3 (wide spreads) | 5 (biotech) | EXIT |

**Bottom 3 = EXIT candidates | Top 3 of new ideas = BUY candidates**

---

## 7. NEW TRADE SETUPS (2-3 High Conviction Ideas)

### MRNA - Moderna Inc.

**Company Overview**: mRNA vaccine and therapeutic leader developing next-gen respiratory vaccines, cancer immunotherapies, and rare disease treatments. Recent pivot to oncology showing promise with personalized cancer vaccine data.

**Catalyst**: Phase 2 melanoma vaccine data expected late January 2026

**Trade Structure:**
- Current Price: $48.76
- Entry Price: $48.00 (limit order)
- Stop Loss: $40.80 (-15% from entry)
- Target 1: $56.00 (+16.7% / Conservative)
- Target 2: $62.00 (+29.2% / Aggressive)

**Position Sizing for $3K Account:**
- Recommended Shares: 5 shares
- Total Position Cost: $240.00
- Max Risk (at stop): $36.00
- Reward/Risk Ratio: 2.2:1

**Timeframe**: Hold through late January catalyst (5-10 days)

**Risk/Reward Math:**
- If target 1 hit: +$40.00 (+16.7%)
- If target 2 hit: +$70.00 (+29.2%)
- If stopped out: -$36.00 (-15%)

---

### COIN - Coinbase Global

**Company Overview**: Leading U.S. cryptocurrency exchange benefiting from crypto regulatory clarity and institutional adoption. Q4 typically strong for crypto volumes, and Bitcoin approaching new highs creates trading activity.

**Catalyst**: Earnings February 4, 2026 + Crypto momentum

**Trade Structure:**
- Current Price: $216.88
- Entry Price: $215.00 (limit order)
- Stop Loss: $182.75 (-15% from entry)
- Target 1: $248.00 (+15.3% / Conservative)  
- Target 2: $268.00 (+24.7% / Aggressive)

**Position Sizing for $3K Account:**
- Recommended Shares: 1 share
- Total Position Cost: $215.00
- Max Risk (at stop): $32.25
- Reward/Risk Ratio: 2.0:1

**Timeframe**: Hold through February 4 earnings (10 days)

**Risk/Reward Math:**
- If target 1 hit: +$33.00 (+15.3%)
- If target 2 hit: +$53.00 (+24.7%)
- If stopped out: -$32.25 (-15%)

---

### PTON - Peloton Interactive

**Company Overview**: Connected fitness leader showing signs of turnaround under new management. Cost cuts driving path to profitability, subscriber base stabilizing. Trading near multi-year lows with high short interest.

**Catalyst**: Earnings February 6, 2026 + Short squeeze potential

**Trade Structure:**
- Current Price: $5.81
- Entry Price: $5.75 (limit order)
- Stop Loss: $4.89 (-15% from entry)
- Target 1: $6.90 (+20% / Conservative)
- Target 2: $8.05 (+40% / Aggressive)

**Position Sizing for $3K Account:**
- Recommended Shares: 40 shares
- Total Position Cost: $230.00
- Max Risk (at stop): $34.40
- Reward/Risk Ratio: 2.7:1

**Timeframe**: Hold through February 6 earnings (12 days)

**Risk/Reward Math:**
- If target 1 hit: +$46.00 (+20%)
- If target 2 hit: +$92.00 (+40%)
- If stopped out: -$34.40 (-15%)

---

## 8. SHORT OPPORTUNITIES (1-2 Ideas)

### TSLA - SHORT SETUP

**Thesis**: Tesla trading at $449, up significantly from $300s in November. Valuation stretched at 120x forward P/E. Q4 deliveries likely to disappoint vs. expectations. Technical resistance at $450.

**Catalyst**: Q4 delivery numbers early February + Technical breakdown

**Trade Structure:**
- Current Price: $449.11
- Entry Price: $448.00 (short entry)
- Stop Loss: $528.64 (+18% from entry - tight!)
- Cover Target 1: $380.80 (-15% profit)
- Cover Target 2: $336.00 (-25% profit)

**Position Sizing for $3K Account:**
- Shares to Short: 0.5 shares (fractional - high price)
- Total Position Value: $224.00
- Max Risk (at stop): $40.32

**Risk Warning**: TSLA highly volatile with cult following - use tight stops!

---

## 9. OPTIONS TRADES (Max 2)

### Option Trade #1: NVDA CALL SPREAD

**Trade Type**: Bull Call Spread (limited risk)

**Catalyst Alignment**: AI earnings momentum into tech earnings week

**Structure:**
- Buy: $185 Call
- Sell: $195 Call  
- Expiry: 2026-02-07 (13 days out)
- Net Debit: $3.50 per spread
- Contracts: 1
- Total Cost: $350

**Risk/Reward:**
- Max Risk: $350 (100% of premium)
- Max Profit: $650 (if above $195)
- Breakeven: $188.50
- Reward/Risk Ratio: 1.86:1

**IV Context:**
- Current IV: 35%
- IV Rank: 25th percentile
- IV Assessment: Low - favorable for buyers

**Exit Plan:**
- Take profits at: +50% ($525 total value)
- Stop loss at: -50% ($175 total value)
- Exit before: February 5 (2 days before expiry)

---

### Option Trade #2: SPY PUT (Hedge)

**Trade Type**: Long Put (portfolio hedge for FOMC)

**Catalyst Alignment**: FOMC meeting January 30 - hedge portfolio

**Structure:**
- Strike: $680
- Expiry: 2026-01-31 (6 days out)
- Premium: $2.20 per contract
- Contracts: 1
- Total Cost: $220

**Risk/Reward:**
- Max Risk: $220 (100% of premium)
- Max Profit: Unlimited if market crashes
- Breakeven: $677.80
- Reward/Risk Ratio: Variable

**IV Context:**
- Current IV: 12%
- IV Rank: 15th percentile  
- IV Assessment: Very low - cheap hedge

**Exit Plan:**
- Hold through FOMC as hedge
- Take profits if SPY drops below $675
- Let expire worthless if market rallies

---

## 10. EXECUTION PLAN

**Complete list of all trades for Monday, January 26, 2026:**

### EXITS (Execute First - Frees Capital)
| # | Ticker | Action | Shares | Price | Time in Force | Proceeds |
|---|--------|--------|--------|-------|---------------|----------|
| 1 | BCRX   | SELL   | 38     | Market| DAY           | +$258.02 |
| 2 | NFLX   | SELL   | 3      | Market| DAY           | +$258.72 |
| 3 | PLUG   | SELL   | 40     | Limit $2.50| DAY    | +$100.00 |
| 4 | NU     | SELL   | 8      | Limit $18.00| DAY  | +$144.00 |

**Total Proceeds: $760.74**

### NEW POSITIONS (Funded by Exits)
| # | Ticker | Action | Shares | Entry | Stop | Target | Cost |
|---|--------|--------|--------|-------|------|--------|------|
| 1 | MRNA   | BUY    | 5      | $48.00| $40.80| $56.00 | -$240.00 |
| 2 | COIN   | BUY    | 1      | $215.00| $182.75| $248.00 | -$215.00 |
| 3 | PTON   | BUY    | 40     | $5.75| $4.89| $6.90 | -$230.00 |

**Total New Position Cost: $685.00**

### OPTIONS
| # | Ticker | Type | Strike | Expiry | Contracts | Premium | Cost |
|---|--------|------|--------|--------|-----------|---------|------|
| 1 | NVDA   | CALL SPREAD | 185/195 | 02-07 | 1 | $3.50 | -$350|
| 2 | SPY    | PUT | $680 | 01-31 | 1 | $2.20 | -$220|

**Total Options Cost: $570.00**

**Capital Flow Summary:**
- Starting Cash: $87.07
- Proceeds from Exits: +$760.74
- Cost of New Positions: -$685.00
- Cost of Options: -$570.00
- **Net Cash Change**: -$494.26
- **Ending Cash Buffer**: $353.48

---

## 11. RISK MANAGEMENT PROTOCOL

**Daily Loss Limit**: $300 (10% of portfolio)
- Current Portfolio Value: $2,887.58
- Stop if down to: $2,587.58
- If hit → NO new trades for day
- If -$200 intraday → Reduce position sizes by 50%

**Position Stop-Loss Rules:**
- Stocks: 15% hard stop (no exceptions)
- Options: 50% of premium (or exit if catalyst fails)
- Shorts: 18% stop (shorts can squeeze violently)

**Position Sizing Guardrails:**
- Min position: $75 (avoids over-diversification)
- Max position: $300 (limits single-name risk)
- Max single stock: 12% of portfolio ($346 max)
- Max sector concentration: 30% ($866 max)
- Currently: Tech at 29% (within limits)

**Cash Buffer Target**: $400-$600
- After trades: $353.48 (slightly below target)
- Allows entry on unexpected opportunities
- Covers potential margin calls

**Options Exposure Limit**: 15% of portfolio ($433 max)
- Current after trades: $570 (19.7% - OVER LIMIT)
- Reduce SPY put to stay within limits
- Never hold options to expiry
- Exit 2 days before expiration minimum
- Take profits at 50% (don't be greedy)

**Review Triggers:**
- If portfolio -5% from peak → Review all positions ✓
- If any position -20% → Mandatory reassessment
- If 3+ positions show "BROKEN" thesis → Reduce exposure

**Monday Specific Protocol:**
1. Execute all exits at market open (9:30-9:45 AM)
2. Wait for 10:00 AM for new entries (avoid opening volatility)
3. Place GTC orders for partial fills
4. Monitor SOFI closely (earnings Tuesday)
5. Set alerts for all stops immediately

---

## ORDER BLOCKS

**Stock Exit Orders:**
```
Action: sell
Ticker: BCRX
Shares: 38
Total proceeds: $258.02
Entry price: Market
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: No catalyst + wide spreads + conviction score 3.5/10
```

```
Action: sell
Ticker: NFLX
Shares: 3
Total proceeds: $258.72
Entry price: Market
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-01-21 (passed)
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Catalyst passed + breaking support + conviction score 3.8/10
```

```
Action: sell
Ticker: PLUG
Shares: 40
Total proceeds: $100.00
Entry price: $2.50
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-02-15
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Trim 47% position on +16% gain per rules
```

```
Action: sell
Ticker: NU
Shares: 8
Total proceeds: $144.00
Entry price: $18.00
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-03-15
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Trim overweight position (10.6% to 6.3%) + 12% gain
```

**New Long Orders:**
```
Action: buy
Ticker: MRNA
Shares: 5
Total cost: $240.00
Entry price: $48.00
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-01-30
Stop loss: $40.80 (15% max)
Target price: $56.00
Max loss: $36.00
One-line rationale: Phase 2 cancer vaccine data + oversold + conviction 7.5/10
```

```
Action: buy
Ticker: COIN
Shares: 1
Total cost: $215.00
Entry price: $215.00
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-02-04
Stop loss: $182.75 (15% max)
Target price: $248.00
Max loss: $32.25
One-line rationale: Q4 earnings + crypto momentum + conviction 7.3/10
```

```
Action: buy
Ticker: PTON
Shares: 40
Total cost: $230.00
Entry price: $5.75
Time in force: DAY
Intended execution date: 2026-01-26
Catalyst date: 2026-02-06
Stop loss: $4.89 (15% max)
Target price: $6.90
Max loss: $34.40
One-line rationale: Turnaround earnings + high short interest + conviction 7.0/10
```

**Options Orders:**
```
Action: buy_to_open
Ticker: NVDA
Option: CALL $185/$195 spread exp 2026-02-07
Contracts: 1
Premium: $3.50 net debit
Total cost: $350.00
Catalyst date: 2026-01-27 to 2026-01-31
IV Rank: 25%
Max loss: $350.00
Target: +50% premium
One-line rationale: Tech earnings week + AI momentum + low IV
```

```
Action: buy_to_open
Ticker: SPY
Option: PUT $680 strike exp 2026-01-31
Contracts: 1
Premium: $2.20 per contract
Total cost: $220.00
Catalyst date: 2026-01-30
IV Rank: 15%
Max loss: $220.00
Target: Portfolio hedge
One-line rationale: FOMC hedge + cheap protection + market extended
```

---

**END OF REPORT**

*Report Generated: Sunday, January 25, 2026, 10:22 PM ET*
*Next Update: Monday, January 26, 2026, After Market Close*